High genotyping concordance between the digene HPV Genotyping RH Test and the Reverse Line Blot genotyping assay on GP5+/6+-PCR products

Journal of Clinical Virology

Volumn 46, Issue SUPPL. 3, 2009, Pages

  Geraets, D T ^a   Heideman, D A M ^b   de Koning, M N C ^a   Snijders, P J F ^b   Meijer, C J L M ^b   van Doorn, L J ^a   Quint, W G V ^a  

^a DDL DIAGNOSTIC LABORATORY   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Genotyping; GP5+ 6+ PCR; Human papillomavirus; Hybrid Capture 2; Reverse hybridization strip; Reverse Line Blot

Indexed keywords

ADULT; ARTICLE; ASSAY; CLINICAL TRIAL; CONTROLLED STUDY; DIGENE HPV GENOTYPING RH TEST; FEMALE; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REVERSE LINE BLOT GENOTYPING ASSAY; SCREENING TEST; SENSITIVITY AND SPECIFICITY; TASK PERFORMANCE; UTERINE CERVIX CYTOLOGY; VIRUS DETECTION; WART VIRUS;

ADULT; ALPHAPAPILLOMAVIRUS; CERVICAL INTRAEPITHELIAL NEOPLASIA; DNA PROBES; DNA, VIRAL; FEMALE; GENES, VIRAL; HUMANS; LABORATORY TECHNIQUES AND PROCEDURES; MASS SCREENING; MIDDLE AGED; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION; REAGENT KITS, DIAGNOSTIC; SENSITIVITY AND SPECIFICITY; SPECIES SPECIFICITY; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 72249116495     PISSN: 13866532     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1386-6532(09)70296-3     Document Type: Article

References (15)

1. Munoz N., Bosch F.X., de Sanjose S., Herrero R., Castellsague X., Shah K.V., et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 348 6 (2003) 518-527
2. Cuzick J., Arbyn M., Sankaranarayanan R., Tsu V., Ronco G., Mayrand M.H., et al. Overview of human papillomavirus-based and other novel options for cervical cancer screening in developed and developing countries. Vaccine 26 Suppl 10 (2008) K29-K41
3. Meijer C.J., Berkhof J., Castle P.E., Hesselink A.T., Franco E.L., Ronco G., et al. Guidelines for human papillomavirus DNA test requirements for primary cervical cancer screening in women 30 years and older. Int J Cancer 124 3 (2009) 516-520
4. van den Brule A.J., Pol R., Fransen-Daalmeijer N., Schouls L.M., Meijer C.J., and Snijders P.J. GP5+/6+ PCR followed by reverse line blot analysis enables rapid and high-throughput identification of human papillomavirus genotypes. J Clin Microbiol 40 3 (2002) 779-787
5. Berkhof J., Bulkmans N.W., Bleeker M.C., Bulk S., Snijders P.J., Voorhorst F.J., et al. Human papillomavirus type-specific 18-month risk of high-grade cervical intraepithelial neoplasia in women with a normal or borderline/mildly dyskaryotic smear. Cancer Epidemiol Biomarkers Prev 15 7 (2006) 1268-1273
6. Bulk S., Berkhof J., Bulkmans N.W., Zielinski G.D., Rozendaal L., van Kemenade F.J., et al. Preferential risk of HPV 16 for squamous cell carcinoma and of HPV 18 for adenocarcinoma of the cervix compared to women with normal cytology in The Netherlands. Br J Cancer 94 1 (2006) 171-175
7. Meijer C.J., Snijders P.J., and Castle P.E. Clinical utility of HPV genotyping. Gynecol Oncol 103 1 (2006) 12-17
8. Hesselink A.T., Bulkmans N.W., Berkhof J., Lorincz A.T., Meijer C.J., and Snijders P.J. Cross-sectional comparison of an automated hybrid capture 2 assay and the consensus GP5+/6+ PCR method in a population-based cervical screening program. J Clin Microbiol 44 10 (2006) 3680-3685
9. Snijders P.J., van den Brule A.J., Jacobs M.V., Pol R.P., and Meijer C.J. HPV DNA detection and typing in cervical scrapes. Methods Mol Med 119 (2005) 101-114
10. van Doorn L.J., Quint W., Kleter B., Molijn A., Colau B., Martin M.T., et al. Genotyping of human papillomavirus in liquid cytology cervical specimens by the PGMY Line Blot Assay and the SPF10 Line Probe Assay. J Clin Microbiol 40 3 (2002) 979-983
11. Castle P.E., Porras C., Quint W.G., Rodriguez A.C., Schiffman M., Gravitt P.E., et al. Comparison of two PCR-based human papillomavirus genotyping methods. J Clin Microbiol 46 10 (2008) 3437-3445
12. Peyton C.L., Schiffman M., Lorincz A.T., Hunt W.C., Mielzynska I., Bratti C., et al. Comparison of PCR- and hybrid capture-based human papillomavirus detection systems using multiple cervical specimen collection strategies. J Clin Microbiol 36 11 (1998) 3248-3254
13. Poljak M., Marin I.J., Seme K., and Vince A. Hybrid Capture II HPV Test detects at least 15 human papillomavirus genotypes not included in its current high-risk probe cocktail. J Clin Virol 25 Suppl 3 (2002) S89-S97
14. Castle P.E., Solomon D., Wheeler C.M., Gravitt P.E., Wacholder S., and Schiffman M. Human papillomavirus genotype specificity of Hybrid Capture 2. J Clin Microbiol 46 8 (2008) 2595-2604
15. van Doorn L.J., Molijn A., Kleter B., Quint W., and Colau B. Highly effective detection of human papillomavirus 16 and 18 DNA by a testing algorithm combining broad-spectrum and type-specific PCR. J Clin Microbiol 44 9 (2006) 3292-3298